vesnarinone has been researched along with Salivary Gland Neoplasms in 5 studies
Salivary Gland Neoplasms: Tumors or cancer of the SALIVARY GLANDS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Omotehara, F | 4 |
| Kawamata, H | 5 |
| Uchida, D | 4 |
| Hino, S | 4 |
| Nakashiro, K | 5 |
| Fujimori, T | 2 |
| Sato, M | 3 |
| Harada, K | 1 |
| Ikeda, Y | 1 |
| Gohda, H | 1 |
| Yoshida, H | 3 |
| Nishida, T | 1 |
| Ono, K | 1 |
| Kinoshita, M | 1 |
| Adachi, M | 1 |
| Miwa, Y | 1 |
| Hamano, H | 1 |
5 other studies available for vesnarinone and Salivary Gland Neoplasms
| Article | Year |
|---|---|
Vesnarinone, a differentiation inducing drug, directly activates p21(waf1) gene promoter via Sp1 sites in a human salivary gland cancer cell line.
Topics: Antineoplastic Agents; Cell Differentiation; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Electro | 2002 |
Transcriptional activation of cyclin-dependent kinase inhibitor, p21waf1 gene by treatment with a differentiation inducing agent, vesnarinone in a human salivary gland cancer cell line.
Topics: Antineoplastic Agents; Cell Differentiation; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; C | 2003 |
Induction of cyclin-dependent kinase inhibitor, p21WAF1, by treatment with 3,4-dihydro-6-[4-(3,4)-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinoline (vesnarinone) in a human salivary cancer cell line with mutant p53 gene.
Topics: Antineoplastic Agents; Carcinoma, Adenosquamous; Cell Differentiation; Cell Division; Cyclin-Depende | 1997 |
Down-regulation of TSC-22 (transforming growth factor beta-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Cell Transformation, Neoplastic; Clone Cells; DNA, Antisense; DNA, C | 1998 |
Induction of TSC-22 by treatment with a new anti-cancer drug, vesnarinone, in a human salivary gland cancer cell.
Topics: Antineoplastic Agents; Cell Cycle; Cell Division; Humans; Neoplasm Proteins; Oligonucleotides, Antis | 1998 |